Announcements Trials
Browse Landscape

Status

No longer available 1Available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 49Observational 10Expanded_access 2

Sponsor

Cancer Type

Myeloid 2

Conditions

Carcinoma, Non-Small-Cell Lung 14Neoplasms 11Multiple Myeloma 10Recurrence 9Pancreatic Neoplasms 8Prostatic Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Melanoma 6Sarcoma 5Ovarian Neoplasms 5Leukemia, Myeloid, Acute 5Hematologic Neoplasms 4Glioblastoma 4Colorectal Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 3Osteosarcoma 3Non-Muscle Invasive Bladder Neoplasms 3Neuroectodermal Tumors, Primitive 3Myelodysplastic Syndromes 3Lymphoma, Large B-Cell, Diffuse 3Lung Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Squamous Cell 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Primary Myelofibrosis 2Polycythemia Vera 2

Interventions

ruxolitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × Polycythemia Vera × 1 year × Clear all
NCT04745637 2025-11-18

Managed Access Programs for INC424, Ruxolitinib

Novartis

Available
Myeloid

Polycythemia Vera, Primary Myelofibrosis

NCT05269771 2025-11-05

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Novartis

No longer available
Myeloid

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡